Skip to main content

Table 3 Method validation for quantification of PN, CA, OPZ, DM, CLZ, and MDZ in inactive RLM

From: Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome

QC (μM)

PN

QC (μM)

CA

QC (μM)

OPZ

Precision and accuracy (%)

Average recovery (%, n = 5)

Precision and accuracy (%)

Average recovery (%, n = 5)

Precision and accuracy (%)

Average recovery (%, n = 5)

Intra-

Inter-

Absolute

Method

Intra-

Inter-

Absolute

Method

Intra-

Inter-

Absolute

Method

a

 3.0

1.19

8.87

106.72 (1.77)

97.17 (1.19)

3.4

0.46

6.64

112.49 (1.12)

113.17 (0.46)

2.8

2.80

2.67

93.45 (7.79)

77.96 (6.02)

 28.0

1.44

3.08

99.12 (3.05)

93.84 (3.30)

34.2

4.15

4.09

97.86 (2.92)

72.37 (4.15)

14.5

0.61

0.78

99.98 (3.70)

94.30 (1.52)

 89.0

7.25

2.32

97.24 (1.22)

87.12 (1.42)

100.0

6.12

4.33

101.32 (6.68)

94.97 (6.12)

58.0

1.67

1.64

97.01 (0.32)

100.16 (0.65)

QC (μM)

CLZ

QC (μM)

MDZ

QC (μM)

DM

Precision and accuracy (%)

Average recovery (%, n = 5)

Precision and accuracy (%)

Average recovery (%, n = 5)

Precision and accuracy (%)

Average recovery (%, n = 5)

Intra-

Inter-

Absolute

Method

Intra-

Inter-

Absolute

Method

Intra-

Inter-

Absolute

Method

b

 6.0

1.26

3.83

94.74 (3.00)

94.48 (0.92)

3.0

3.87

5.29

98.51 (0.9)

100.50 (0.37)

2.7

11.92

10.50

81.50 (12.15)

104.70 (11.92)

 29.5

1.31

4.90

97.14 (1.05)

95.31 (0.58)

15.0

1.93

3.36

100.07 (9.05)

107.18 (1.06)

13.5

5.56

8.56

96.75 (6.46)

98.33 (5.56)

 118.0

2.96

1.97

102.60 (3.26)

97.12 (1.90)

49.0

0.17

2.53

93.42 (4.47)

98.79 (4.43)

43.2

4.43

2.37

99.96 (3.03)

94.45 (2.26)

  1. The numbers in the brackets represented RSD%